CARDIOVASCULAR SAFETY AND BASIS THERAPY OF COPD
Chronic obstructive pulmonary disease (COPD) is a progressing disease with incompletely reversible airflow obstruction caused by various factors, the most important of which is smoking [1, 2]. According to a number of recently completed studies, COPD is found in 10.1% (11.8% men and 8.5% women) of people over 40 years globally [3] over 16 million people in Russia suffer from COPD [4]. COPD is one of the most crucial healthcare and social challenges due to high incidence of the disease and high risk of serious complications that lead to disability and death affecting also working population [1, 2].